Kaizen Financial Strategies decreased its position in shares of JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report) by 23.3% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 62,803 shares of the company’s stock after selling 19,082 shares during the period. JPMorgan International Research Enhanced Equity ETF makes up about 2.1% of Kaizen Financial Strategies’ investment portfolio, making the stock its 14th largest position. Kaizen Financial Strategies’ holdings in JPMorgan International Research Enhanced Equity ETF were worth $5,160,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Envestnet Asset Management Inc. boosted its stake in shares of JPMorgan International Research Enhanced Equity ETF by 3.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 3,208,978 shares of the company’s stock worth $264,709,000 after purchasing an additional 108,160 shares during the period. EdgeRock Capital LLC raised its position in JPMorgan International Research Enhanced Equity ETF by 27.1% in the 1st quarter. EdgeRock Capital LLC now owns 362,475 shares of the company’s stock worth $27,475,000 after purchasing an additional 77,274 shares during the period. Kestra Advisory Services LLC raised its position in JPMorgan International Research Enhanced Equity ETF by 32.4% in the 1st quarter. Kestra Advisory Services LLC now owns 29,056 shares of the company’s stock worth $2,201,000 after purchasing an additional 7,111 shares during the period. Kintra Wealth LLC bought a new stake in JPMorgan International Research Enhanced Equity ETF in the second quarter worth about $10,016,000. Finally, World Investment Advisors bought a new stake in JPMorgan International Research Enhanced Equity ETF in the fourth quarter worth about $2,271,000.
JPMorgan International Research Enhanced Equity ETF Price Performance
Shares of NYSEARCA:JIRE traded up $0.53 during trading hours on Friday, hitting $81.84. 436,938 shares of the company’s stock traded hands, compared to its average volume of 489,107. The firm has a market capitalization of $10.94 billion, a P/E ratio of 16.04 and a beta of 0.78. The business has a fifty day moving average price of $84.01 and a 200-day moving average price of $81.61. JPMorgan International Research Enhanced Equity ETF has a 1 year low of $71.85 and a 1 year high of $86.07.
JPMorgan International Research Enhanced Equity ETF Company Profile
The JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is managed by JPMorgan Chase.
Read More
- Five stocks we like better than JPMorgan International Research Enhanced Equity ETF
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Want to see what other hedge funds are holding JIRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report).
Receive News & Ratings for JPMorgan International Research Enhanced Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan International Research Enhanced Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
